Bank of Montreal Can grew its position in shares of Dynatrace, Inc. (NYSE:DT – Free Report) by 27.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 910,374 shares of the company’s stock after buying an additional 198,568 shares during the period. Bank of Montreal Can’s holdings in Dynatrace were worth $48,241,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in DT. Eminence Capital LP bought a new position in Dynatrace during the 2nd quarter worth $158,369,000. Assenagon Asset Management S.A. increased its position in Dynatrace by 1,146.0% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,208,137 shares of the company’s stock worth $98,792,000 after buying an additional 2,030,915 shares during the period. Marshall Wace LLP increased its position in Dynatrace by 285.7% during the 2nd quarter. Marshall Wace LLP now owns 1,389,727 shares of the company’s stock worth $62,176,000 after buying an additional 1,029,387 shares during the period. Dorsal Capital Management LP increased its position in Dynatrace by 118.8% during the 2nd quarter. Dorsal Capital Management LP now owns 1,750,000 shares of the company’s stock worth $78,295,000 after buying an additional 950,000 shares during the period. Finally, Allspring Global Investments Holdings LLC increased its position in Dynatrace by 70.8% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,934,499 shares of the company’s stock worth $86,549,000 after buying an additional 801,718 shares during the period. Institutional investors own 94.28% of the company’s stock.
Dynatrace Trading Down 0.3 %
Shares of DT stock opened at $55.46 on Thursday. The business’s 50-day moving average price is $53.66 and its 200-day moving average price is $49.06. Dynatrace, Inc. has a 12 month low of $39.42 and a 12 month high of $61.41. The firm has a market capitalization of $16.55 billion, a price-to-earnings ratio of 100.84, a PEG ratio of 8.09 and a beta of 1.06.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on DT
Insider Activity
In related news, Director Stephen J. Lifshatz sold 5,000 shares of Dynatrace stock in a transaction that occurred on Friday, October 11th. The stock was sold at an average price of $55.00, for a total value of $275,000.00. Following the transaction, the director now directly owns 41,471 shares of the company’s stock, valued at $2,280,905. The trade was a 10.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Dan Zugelder sold 11,022 shares of Dynatrace stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $49.71, for a total value of $547,903.62. Following the completion of the transaction, the executive vice president now directly owns 217,465 shares in the company, valued at approximately $10,810,185.15. This represents a 4.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 66,022 shares of company stock valued at $3,397,904. 0.59% of the stock is currently owned by corporate insiders.
Dynatrace Profile
Dynatrace, Inc provides a security platform for multicloud environments in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates Dynatrace, a security platform, which provides application and microservices monitoring, runtime application security, infrastructure monitoring, log management and analytics, digital experience monitoring, digital business analytics, and cloud automation.
Read More
- Five stocks we like better than Dynatrace
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Trading Stocks: RSI and Why it’s Useful
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Find and Profitably Trade Stocks at 52-Week Lows
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding DT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dynatrace, Inc. (NYSE:DT – Free Report).
Receive News & Ratings for Dynatrace Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatrace and related companies with MarketBeat.com's FREE daily email newsletter.